Article
Assessment of exonic polymorphism of IDH2, KRAS1, TP53, and BRAF2 using PCR-RFLP in hepatocellular carcinoma: a case-control study from Arunachal Pradesh and Sikkim.
Personalized medicine - 1 Apr 2026
Chauhan Chetan, Kumar Vishal, Narain Kanwar, Phukan Sanjib K, Kakoty Santanu, Tawsik Sopai, Bhutia Chewang D, Devi Kangjam Rekha
Abstract excerpt
INTRODUCTION: The primary liver cancer of greatest concern is hepatocellular carcinoma (HCC). It covers almost 80% of liver cancer in the global population, and in the next two decades, it is expected to increase by 15%. The biomarker-based study has therapeutic potential to enhance therapy responses for HCC. AIM: Thus, the present study investigates genetic polymorphisms in key genes from HCC patients in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
